Cervicouterine Cancer Screening - TruScreen™ vs. Conventional Cytology: Pilot Study

Area of Science:

• Gynecology
• Oncology
• Medical Devices

Background:

• Cervical cancer (CC) is a significant global health issue, particularly affecting women.
• Advanced stages of CC are more prevalent in developing countries.

Purpose of the Study:

• To compare the diagnostic performance of the TruScreen™ opto-electronic device against conventional cytology for cervical cancer screening.
• To determine the sensitivity and specificity of TruScreen™ in identifying cervical intraepithelial lesions.

Main Methods:

• A prospective observational study involving 32 patients at a Dysplasia Clinic.
• Patients underwent evaluation with TruScreen™, conventional cytology, colposcopy, and biopsy if indicated.
• Statistical analysis included sensitivity, specificity, PPV, and NPV, with conventional cytology as the reference standard.

Main Results:

• TruScreen™ exhibited 43% sensitivity and 92% specificity for high-grade intraepithelial lesions.
• Conventional cytology showed a high negative predictive value (NPV) of 85% for the TruScreen™ device.
• The Kappa agreement index between TruScreen™ and colposcopy was 0.70.

Conclusions:

• TruScreen™ demonstrated lower sensitivity but higher specificity compared to conventional cytology.
• Conventional cytology maintained a high negative predictive value for cervical cancer screening.